ClinicalTrials.Veeva

Menu

Symptom Tracking in Long COVID Patients Using Formula C™ Sublingual Drops

E

Endourage

Status

Completed

Conditions

Long Covid19
Long-Haul COVID-19
Post-Acute COVID-19 Syndrome
Post-Acute COVID-19
Long COVID
Long Haul COVID

Treatments

Combination Product: Endourage Targeted Wellness Formula C™, a full hemp flower extract

Study type

Observational

Funder types

Industry

Identifiers

NCT06163690
Endo2023

Details and patient eligibility

About

This is a digital symptom tracking study of Formula C™, a full cannabis flower formulation, rich in cannabinoids and terpenes, that has been shown to improve symptoms in people with Long COVID. Participants 21 and older will take Formula C™ for 90 days. During that time, participants will answer weekly surveys to track symptoms and wellbeing.

Full description

Long COVID is a global health crisis with no current treatments. There's a growing interest within the medical community to explore the potential benefits of full hemp flower extracts in treating and alleviating Long COVID symptoms. Full hemp flower extracts are a remarkable advancement in the field of natural wellness and healing. Full hemp flower extracts harness the full spectrum of beneficial compounds present in the hemp plant, including not just cannabidiol (CBD), but a host of other cannabinoids, terpenes, and flavonoids. This process, known as 'whole plant' or 'full spectrum' extraction, produces a more potent and therapeutic product, as the various compounds work synergistically in what is referred to as the 'entourage effect'. These extracts have been associated with a broad range of potential health benefits, such as pain relief, reduction of inflammation, anxiety management, and sleep improvement. A recently published single-blind, randomized, placebo controlled trial demonstrated that Long COVID patients benefitted from sublingual use of Formula C without any safety events. This remote, observational study of Endourage Targeted Wellness Formula C™ sublingual drops will seek to empower participants to track symptoms and wellbeing while taking Formula C to determine if Long COVID symptoms are attenuated and time to healing is shortened.

Enrollment

20 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Must be at least 21 years of age.
  2. Willing and able to read, understand, and sign the informed consent.
  3. Willing to comply with all study procedures.
  4. Must have device to access the internet to complete surveys online.
  5. A diagnosis of Long COVID from a health care provider.

Exclusion criteria

  1. Non-English speaking, as the surveys are developed in the English language.
  2. Known allergies to hemp seeds or hemp-derived products, medical cannabis, coconut oil.
  3. Pregnancy, or planning to become pregnant in the next 3 months

Trial contacts and locations

1

Loading...

Central trial contact

Michael Steward, MD; Isaac Foster

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems